Rejuvenating cells to reverse age-related diseases.
Life Biosciences is a biotechnology company pioneering cellular rejuvenation using epigenetic restoration to reverse diseases of aging.
Rejuvenating cells to reverse age-related diseases.
Life Biosciences is a biotechnology company pioneering cellular rejuvenation using epigenetic restoration to reverse diseases of aging.
Targeting the biology of aging
Aging is the biggest risk factor for most chronic diseases. Groundbreaking research has demonstrated that cells can be rejuvenated by a process called epigenetic restoration that reverts cells to a younger, healthier state. This approach holds the promise of addressing many of the most debilitating age-related diseases of our time.
Our Platform Technology
Life Biosciences’ epigenetic restoration platform enables the rejuvenation of aged and injured cells to restore cellular function. This approach has potential therapeutic application in a wide range of age-related diseases.
News
- April 8, 2026
Life Biosciences Secures $80 Million Series D Financing - January 28, 2026
Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies - November 3, 2025
Life Biosciences Appoints Industry Veteran David Guyer, M.D. to Board of Directors - August 26, 2025
Life Biosciences Presents New Data at ARDD 2025 on the Company’s Partial Epigenetic Reprogramming Platform in Liver and Ocular Diseases - July 22, 2025
Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies
